Literature DB >> 22578097

Electroclinical pattern in MECP2 duplication syndrome: eight new reported cases and review of literature.

Aglaia Vignoli1, Renato Borgatti, Angela Peron, Claudio Zucca, Lucia Ballarati, Clara Bonaglia, Melissa Bellini, Lucio Giordano, Romina Romaniello, Maria Francesca Bedeschi, Roberta Epifanio, Silvia Russo, Rossella Caselli, Daniela Giardino, Francesca Darra, Francesca La Briola, Giuseppe Banderali, Maria Paola Canevini.   

Abstract

PURPOSE: Duplications encompassing the MECP2 gene on the Xq28 region have been described in male patients with moderate to severe mental retardation, absent speech, neonatal hypotonia, progressive spasticity and/or ataxia, recurrent severe respiratory infections, gastrointestinal problems, mild facial dysmorphisms (midface hypoplasia, depressed nasal bridge, large ears) and epilepsy. Epilepsy can occur in >50% of cases, but the types of seizures and the electroclinical findings in affected male individuals have been poorly investigated up to the present. Herein we describe eight patients with MECP2 duplication syndrome and a specific clinical and electroencephalographic pattern.
METHODS: Array CGH of genomic DNA from the probands was performed, and an Xq28 duplication ranging from 209 kb to 6.36 Mb was found in each patient. Electroencephalography studies and clinical and seizure features of all the patients were analyzed. KEY
FINDINGS: We found that epilepsy tended to occur between late childhood and adolescence. Episodes of loss of tone of the head and/or the trunk were the most represented seizure types. Generalized tonic-clonic seizures were rarely observed. The typical interictal EEG pattern showed abnormal background activity, with generalized slow spike and wave asynchronous discharge with frontotemporal predominance. Sleep electroencephalography studies also demonstrated abnormal background activity; spindles and K complex were often abnormal in morphology and amplitude. Response to therapy was generally poor and drug resistance was a significant feature. SIGNIFICANCE: Although these cases and a review of the literature indicate that epilepsy associated with MECP2 duplication syndrome cannot be considered a useful marker for early diagnosis, epilepsy is present in >90% of adolescent patients and shows a peculiar electroclinical pattern. Consequently, it should be considered a significant sign of the syndrome, and an EEG follow-up of these patients should be encouraged from early childhood. Moreover, the definition of a more specific epileptic phenotype could be useful in order to suspect MECP2 duplication syndrome in older undiagnosed patients. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22578097     DOI: 10.1111/j.1528-1167.2012.03501.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Brief report: regression timing and associated features in MECP2 duplication syndrome.

Authors:  S U Peters; R J Hundley; A K Wilson; C M B Carvalho; J R Lupski; M B Ramocki
Journal:  J Autism Dev Disord       Date:  2013-10

Review 2.  X-linked intellectual disability update 2017.

Authors:  Giovanni Neri; Charles E Schwartz; Herbert A Lubs; Roger E Stevenson
Journal:  Am J Med Genet A       Date:  2018-04-25       Impact factor: 2.802

3.  Spectrum and time course of epilepsy and the associated cognitive decline in MECP2 duplication syndrome.

Authors:  Dana Marafi; Bernhard Suter; Rebecca Schultz; Daniel Glaze; Valory N Pavlik; Alica M Goldman
Journal:  Neurology       Date:  2018-12-14       Impact factor: 9.910

4.  A sibship with duplication of Xq28 inherited from the mother; genomic characterization and clinical outcomes.

Authors:  Dong Keon Yon; Ji Eun Park; Seung Jun Kim; Sung Han Shim; Kyu Young Chae
Journal:  BMC Med Genet       Date:  2017-03-17       Impact factor: 2.103

5.  Clinical and molecular genetic characterization of familial MECP2 duplication syndrome in a Chinese family.

Authors:  Xiaoyan Li; Hua Xie; Qian Chen; Xiongying Yu; Zhaoshi Yi; Erzhen Li; Ting Zhang; Jian Wang; Jianmin Zhong; Xiaoli Chen
Journal:  BMC Med Genet       Date:  2017-11-15       Impact factor: 2.103

6.  Valproic acid as a monotherapy in drug-resistant methyl-CpG-binding protein 2 gene (MECP2) duplication-related epilepsy.

Authors:  Meghna Rajaprakash; Julie Richer; Erick Sell
Journal:  Epilepsy Behav Case Rep       Date:  2018-10-09

7.  Infectious and immunologic phenotype of MECP2 duplication syndrome.

Authors:  Michael Bauer; Uwe Kölsch; Renate Krüger; Nadine Unterwalder; Karin Hameister; Fabian Marc Kaiser; Aglaia Vignoli; Rainer Rossi; Maria Pilar Botella; Magdalena Budisteanu; Monica Rosello; Carmen Orellana; Maria Isabel Tejada; Sorina Mihaela Papuc; Oliver Patat; Sophie Julia; Renaud Touraine; Thusari Gomes; Kirsten Wenner; Xiu Xu; Alexandra Afenjar; Annick Toutain; Nicole Philip; Aleksandra Jezela-Stanek; Ludwig Gortner; Francisco Martinez; Bernard Echenne; Volker Wahn; Christian Meisel; Dagmar Wieczorek; Salima El-Chehadeh; Hilde Van Esch; Horst von Bernuth
Journal:  J Clin Immunol       Date:  2015-02-27       Impact factor: 8.317

Review 8.  A brief history of MECP2 duplication syndrome: 20-years of clinical understanding.

Authors:  Daniel Ta; Jenny Downs; Gareth Baynam; Andrew Wilson; Peter Richmond; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2022-03-21       Impact factor: 4.123

9.  MECP2 duplication syndrome: The electroclinical features of a case with long-term evolution.

Authors:  Ilaria Cani; Lorenzo Muccioli; Francesco Mignani; Laura Licchetta; Paolo Tinuper; Federica Provini; Francesca Bisulli
Journal:  Epilepsy Behav Rep       Date:  2022-04-19

Review 10.  Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies.

Authors:  Kirill Smirnov; Tatiana Stroganova; Sophie Molholm; Olga Sysoeva
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.